Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.11.25
/
50%
€23.00
Target price
24.11.26
-
Performance (%)
22.61%
Price
10.04.26
€28.20
Summary
This prediction is currently active. The prediction currently has a performance of 22.61%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -7.843% | -7.843% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€32.19
24.12.26
24.12.26
18.49%
10.04.26
10.04.26
